Browse studies
Find your next paid study
38 recruiting studies matching your filters
Phase 1
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) in…
Breast CancerPALB2-Mutated Breast CarcinomaHER2-negative Breast Cancer+2 more
Estimated
~$10 – $7,500
Dana-Farber Cancer InstituteNCT06488378
Phase 2
FITWISE: Feasibility Study of Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
This clinical trial aims to evaluate the effectiveness of tirzepatide in achieving a 5% or more body weight reduction in patients undergoing adjuvant treatment…
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Estimated
~$10 – $6,250
Rutgers, The State University of New JerseyNCT06518837